ストックスクリーナーアプリを入手
4.29
0.69%
-0.03
アフターアワーズ：
4.23
-0.06
-1.40%
前日終値:
$4.32
開ける：
$4.29
24時間の取引高:
221.34K
Relative Volume:
0.08
時価総額：
$75.77M
収益：
-
当期純損益:
$-30.54M
株価収益率:
-2.7677
EPS:
-1.55
ネットキャッシュフロー:
$-18.30M
1週間 パフォーマンス:
+0.47%
1か月 パフォーマンス:
+2.14%
6か月 パフォーマンス:
+724.37%
1年 パフォーマンス:
+1,249%
1日の値動き範囲:
$4.235
$4.35
1週間の範囲:
$4.07
$4.35
52週間の値動き範囲:
$0.2833
$8.2457
Unicycive Therapeutics Inc Stock (UNCY) Company Profile
名前
Unicycive Therapeutics Inc
セクター
電話
650-384-0642
住所
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
UNCY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
UNCY
Unicycive Therapeutics Inc
|
4.29 | 74.00M | 0 | -30.54M | -18.30M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.62 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.80 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.23 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
722.01 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.26 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-21 | 開始されました | Guggenheim | Buy |
| 2024-04-04 | 開始されました | Piper Sandler | Overweight |
Unicycive Therapeutics Inc (UNCY) 最新ニュース
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - FinancialContent
What MACD and RSI say about Unicycive Therapeutics Inc.2025 Price Targets & Verified Chart Pattern Signals - Newser
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain OfficersUNCY - MarketScreener
Investor Alert: Deadline Approaching to Join Unicycive Therapeutics, Inc. (UNCY) Class ActionContact Levi & Korsinsky - Newsfile
Risk adjusted return profile for Unicycive Therapeutics Inc. analyzed2025 Winners & Losers & Weekly Setup with High ROI Potential - Newser
Is Unicycive Therapeutics Inc. stock entering bullish territoryWeekly Gains Report & Daily Profit Focused Screening - Newser
Shareholders of Unicycive Therapeutics, Inc. (UNCY): Protect Your Rights Before October 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
What candlestick patterns are forming on Unicycive Therapeutics Inc.Trade Entry Report & Expert Curated Trade Setup Alerts - Newser
Risk vs reward if holding onto Unicycive Therapeutics Inc.Weekly Market Outlook & Target Return Focused Stock Picks - Newser
Custom watchlist performance reports with Unicycive Therapeutics Inc.Short Setup & Capital Efficiency Focused Strategies - Newser
Unicycive Therapeutics, Inc. Sued for Securities Law - GlobeNewswire
Tools to monitor Unicycive Therapeutics Inc. recovery probability2025 Price Action Summary & Long-Term Growth Plans - Newser
Is this a good reentry point in Unicycive Therapeutics Inc.July 2025 Market Mood & AI Powered Market Entry Strategies - Newser
How to monitor Unicycive Therapeutics Inc. with trend dashboardsPortfolio Risk Report & Free Long-Term Investment Growth Plans - Newser
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Contact Levi & Korsinsky to Join Class Action Before October 14, 2025 - ACCESS Newswire
Earnings visualization tools for Unicycive Therapeutics Inc.2025 Top Gainers & Scalable Portfolio Growth Methods - Newser
Can Unicycive Therapeutics Inc. weather a recessionJuly 2025 Action & Accurate Buy Signal Alerts - خودرو بانک
UNCY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Does Unicycive Therapeutics Inc. have declining or rising EPSJuly 2025 Fed Impact & High Accuracy Swing Trade Signals - خودرو بانک
Will Unicycive Therapeutics Inc. stock go up in YEARTrade Risk Assessment & AI Forecasted Stock Moves - خودرو بانک
Is Unicycive Therapeutics Inc. impacted by rising ratesWeekly Trend Recap & Risk Controlled Daily Plans - خودرو بانک
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Urged to Join Class Action Before October 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
How hedge fund analytics apply to Unicycive Therapeutics Inc. stockWeekly Market Report & Community Consensus Picks - Newser
UNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Will Unicycive Therapeutics Inc. stock recover after recent dropGold Moves & Long-Term Growth Portfolio Plans - Newser
Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. (UNCY) Shareholders of Class Action Lawsuit and October 14, 2025 Deadline - ACCESS Newswire
Is Unicycive Therapeutics Inc. stock reversal real or fakeQuarterly Performance Summary & Community Verified Watchlist Alerts - Newser
Levi & Korsinsky Urges Unicycive Therapeutics, Inc. (UNCY) Shareholders to Act Before Lead Plaintiff Deadline October 14, 2025 - ACCESS Newswire
Candlestick signals on Unicycive Therapeutics Inc. stock today2025 Trading Recap & Daily Stock Trend Reports - Newser
Can machine learning forecast Unicycive Therapeutics Inc. recoveryPortfolio Risk Summary & Stock Market Timing Techniques - Newser
Can momentum traders help lift Unicycive Therapeutics Inc.Weekly Profit Recap & Weekly Watchlist of Top Performers - Newser
Will Unicycive Therapeutics Inc. face regulatory challengesQuarterly Market Review & AI Powered Buy and Sell Recommendations - sundaytimes.kr
Bragar Eagel & Squire, P.C. Reminds Investors of Unicycive, Nutex, and Snap that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Unicycive Therapeutics (NASDAQ:UNCY) Upgraded by Wall Street Zen to Hold Rating - Defense World
Is Unicycive Therapeutics Inc. in Accumulation Phase Now getLinesFromResByArray error: size == 0 - thegnnews.com
How to track smart money flows in Unicycive Therapeutics Inc.Jobs Report & Free Community Consensus Stock Picks - Newser
Combining machine learning predictions for Unicycive Therapeutics Inc.2025 Top Gainers & Daily Price Action Insights - Newser
Faruqi & Faruqi investigates Unicycive Therapeutics securities class action. - AInvest
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers – UNCY - FinancialContent
Published on: 2025-08-29 05:29:20 - Newser
Unicycive Therapeutics Inc (UNCY) 財務データ
収益
当期純利益
現金流量
EPS
1.14%
1.34%
大文字化:
|
ボリューム (24 時間):